sameAs
Activin receptor IIBForkhead box C2Activin A receptor, type II-like 1PodoplaninBone morphogenetic protein receptor type 2Collagen and calcium binding EGF domains 1Prospero homeobox 1Fms related receptor tyrosine kinase 4Protein phosphatase 3 catalytic subunit betaProtein tyrosine phosphatase non-receptor type 14Prospero homeobox 2SRY-box transcription factor 18Protein phosphatase 3, catalytic subunit, beta isoformCollagen and calcium binding EGF domains 1Bone morphogenetic protein receptor, type II (serine/threonine kinase)Nuclear factor of activated T-cells, cytoplasmic 1PodoplaninSRY (sex determining region Y)-box 18Prospero homeobox 1Prospero homeobox 2Protein tyrosine phosphatase, non-receptor type 14Vascular endothelial growth factor AFMS-like tyrosine kinase 4PodoplaninFms related receptor tyrosine kinase 4Activin A receptor like type 1Forkhead box C2Bone morphogenetic protein receptor type 2SRY-box transcription factor 18Prospero homeobox 2Prospero homeobox 2Activin A receptor type 2BActivin A receptor like type 1Forkhead box C2Forkhead box C2
P682
An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situAnalysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24Prox1 is a master control gene in the program specifying lymphatic endothelial cell fateAutocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cellsMutations in CCBE1 cause generalized lymph vessel dysplasia in humansCCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activationPrognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancerTumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesisRole of hypoxia and vascular endothelial growth factors in lymphangiogenesisLymphangiogenesis and Lesion Heterogeneity in Interstitial Lung DiseasesAngiogenesis and lymphangiogenesis in primary cutaneous T-cell lymphomasLymphangiogenesis and metastasis--a closer look at the neuropilin/semaphorin3 axisTumor angiogenesis and lymphangiogenesis: tumor/endothelial crosstalk and cellular/microenvironmental signaling mechanismsRole of tumor associated macrophages in tumor angiogenesis and lymphangiogenesisCancer-stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasisMouse models for studying angiogenesis and lymphangiogenesis in cancerPressing the right buttons: signaling in lymphangiogenesisIntravital Imaging Reveals Dynamics of Lymphangiogenesis and Valvulogenesis.Three-dimensional imaging of Prox1-EGFP transgenic mouse gonads reveals divergent modes of lymphangiogenesis in the testis and ovaryMyeloid cells contribute to tumor lymphangiogenesisThe role of lymphangiogenesis and angiogenesis in tumor metastasisVascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis.Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skinRelationship among expression of vascular endothelial growth factor-C(VEGF-C), angiogenesis, lymphangiogenesis, and lymphatic metastasis in oral cancerVEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membraneRegulation of developmental lymphangiogenesis by Syk(+) leukocytesPodoplanin expression in cancerous stroma induces lymphangiogenesis and predicts lymphatic spread and patient survivalRole of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spreadAn in vivo method to quantify lymphangiogenesis in zebrafishVEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesisCold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response elementTumor-derived interleukin-1 promotes lymphangiogenesis and lymph node metastasis through M2-type macrophagesδ-Catenin activates Rho GTPase, promotes lymphangiogenesis and growth of tumor metastasesProx1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesisLymphangiogenesis is required for pancreatic islet inflammation and diabetesmTOR activation, lymphangiogenesis, and estrogen-mediated cell survival: the "perfect storm" of pro-metastatic factors in LAM pathogenesisMolecular regulation of angiogenesis and lymphangiogenesisMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.Vascular endothelial growth factor C-induced lymphangiogenesis decreases tumor interstitial fluid pressure and tumorAbnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms.
P921
Q14905181-A810D228-FC1F-4366-A571-E3467BBF0191Q14905611-161F276B-AA6F-487C-89A4-1368018C855DQ14905611-CB147C57-2D06-4807-8609-47906869B1ADQ14914466-30BB2814-6FD8-495F-9186-CB90F40CC1B1Q2100344-88442E5D-3251-4C29-BC2B-2021B09B96A6Q21106712-9B0D916F-0668-4C72-B405-912F8D72ADC6Q21112984-0C40B976-C3FB-405B-BC44-B30EF1595661Q21112984-BA2D6A05-3BEB-4052-8FE6-F568BFE24C50Q21114237-554469B3-9AFD-4BB7-8D2E-AFA42FA72612Q21114237-CE2D871B-B5E1-4C0C-ABDC-63B02E41ABAEQ21118353-D8074FDB-42A8-4F80-8908-0F7C286B348BQ21118452-5BA53052-5D2E-4235-B501-126AA1F8283DQ21120492-C66D14C4-3DC7-466B-A295-C932AF60D5B2Q21123786-6CEC84DD-72E0-4A6E-BE00-AAB5EBF9BDB4Q21124524-7879E4B9-61FD-42F7-AD74-F38F99E19D6AQ21124524-8EC453CC-D262-4BD0-AFF4-CBCBAFEFC435Q21494816-EBC450C8-B4B1-453D-8DD0-BC03ADE6387FQ21494959-25A18F1A-BDB3-409E-9F79-E28ED47B74D7Q21494959-A79F804A-DEFD-4453-8B3B-04ECE48B7BA0Q21495412-168A0401-5E22-4C37-9559-8D0043F7DFE2Q21987757-C6529175-FCAA-4C97-9427-16EC2C2863CEQ21989861-44A4A7A4-75B3-4135-9778-143DB448B675Q21990150-81766E19-D331-4C04-BEF6-800428287BC1Q21990150-BBFA99F7-061B-4063-987B-DD0EEDF555C3Q21990473-61CB9842-7BFD-4F82-A8D1-F591D1F058A1Q21990476-3216A0B1-54DE-4EB4-BE7D-CEC56F38F08AQ21990497-59A1F01F-C649-4952-AA1A-F8895057061CQ21992409-E90D55F4-6DD7-4CFE-8992-B412C7E42F5EQ21992684-B1BD8111-113F-49B5-9B3D-2AE6445940D2Q28558130-2E7E2CDC-391E-41BD-9FC6-87E74F831D9DQ28559728-34822A43-AD92-4018-B6FB-053505740A78Q28560394-4E26A0DF-6D16-4C09-A6ED-A6A1773A72C0Q28562217-07030862-E1A5-456A-AED0-5FE757E3AC3EQ29520781-C88D937D-0E09-449C-8556-841AEA79CDC0Q29520929-65C6EF29-AA79-456D-91EC-28FD609789C1Q29520929-CD660358-6740-404C-9804-4253D8AA07CBQ29525965-5FF6FCB0-7F12-4845-A68B-F99BA8AC7026Q29836575-E893CDE5-43E6-4D3E-9FAE-3169F00A1D57Q4650908-950C890F-A836-49BA-8C0C-EF71C7B717D5Q4650909-046A1C05-448A-472C-8176-F76E68DF31DB
P682
Q21195234-0FDA81AD-25BF-42E1-839D-37FE6A671B81Q24301349-556999BA-D214-428D-94F3-D33446C2B67EQ24315144-1AF1E078-202B-4883-BC57-D3DA6BA4E537Q24318473-C3847EDC-C85A-4A5C-BCBD-510EB93E1647Q24320350-044C2FFB-4E7A-43F3-84E6-5631A11E6ED7Q24337821-66CC4403-C75F-415A-89D1-A860BF37174AQ24540132-E6A32BD7-4092-4E2D-AF72-C513A0C6E6F7Q24669710-12BB8D8F-953F-4C0C-9019-F3D52F9A6F5FQ26745683-F011593C-9E59-4630-AF85-79330E16A06CQ26773022-DBA789E9-9991-40BB-ADF5-61FF2BD41D1BQ26777374-C22F7F95-6C18-4AEC-A09D-A2B5C40D5E64Q26825144-91E8E714-4DED-4A0A-8A2B-72F3CC8C0674Q26830901-E0E6F09A-FA41-40B5-99A2-11555EB73EB6Q26865533-9ADFC948-E667-4103-9B4F-6AB22CF76BECQ26866144-6E91B0BA-6C7D-450B-A3E0-4E0FB1C9984AQ27003898-C63081C5-CA77-4D12-9716-DB451ADC5703Q27006947-A95E0951-40A0-4734-967C-7C5B2FD44A36Q27301422-4968C38D-9EB5-4558-8115-6D9DA055EE9DQ27324348-6BC299EC-6D66-4BD4-9C04-414B36408915Q27342202-27230252-9353-4A8A-BE64-981930751A5EQ28067309-F6AE9F63-7485-4F43-BB52-9D5F25DDEFC4Q28200101-2FD5D809-7BC7-465C-97F8-99BE8BBA1A0CQ28209860-596884CA-3121-4C2E-9627-2C0CAC1FA61DQ28216079-78D18A34-9E7F-403F-ADFC-4D1C86806438Q28245526-9B5FD8B8-31A4-4E0E-A0A6-85429FD48BE8Q28276055-3A499BB8-F43F-42F2-AF9B-0D5E8DD10874Q28294914-FBF5FADD-BDC8-4BDC-8ECF-5FAF62B57035Q28300973-B611CAED-760B-4B88-A1D0-9F7E4C0CF5E8Q28483763-9A7EEACC-48C5-420E-B960-8A387055EA60Q28509472-49B042D6-C636-45F6-B764-F3B83080D3B4Q28512426-3DFB4414-D836-4DEF-B88C-9073A9BEDD99Q28539655-5808E980-AC33-481C-9D6C-4570F8C7E741Q28543177-CDF5B458-C0A1-4654-96F0-EE1E69FC477FQ28587821-A6F6B2E1-AA1E-45FD-A8CA-E4D2C29B52DBQ28742322-5B87BA4A-6D8B-4606-A0A3-F0FDCEA61D59Q28751693-A870F415-68F3-43E5-99C8-B1EB8673C2B8Q29616150-8BD41D05-EBA1-4E6F-A1D6-B07459DFD007Q30278005-AB057A18-3CFC-48A3-BFFC-F28A4203A04EQ30451661-3378C00D-9385-4DD5-9465-EB7006579F6EQ30486123-5B1F840B-32FB-49DB-A0A2-E323A043C097
P921
description
Lymph vessel formation when ne ...... ation of pre-existing vessels.
@en
Wachstum neuer Lymphgefäße von bereits existierenden Gefäßen
@de
biologisch proces
@nl
name
Lymphangiogenese
@de
lymphangiogenesis
@en
リンパ管新生
@ja
type
label
Lymphangiogenese
@de
lymphangiogenesis
@en
リンパ管新生
@ja
altLabel
GO:0001946
@en
lymph vessel formation
@en
prefLabel
Lymphangiogenese
@de
lymphangiogenesis
@en
リンパ管新生
@ja
P486
P6366
P2888
P3417
Lymphangiogenesis
P486
P6366
2776636583
P686
GO:0001946